FDA approves Mylan's generic Zofran

06/25/2007 | Forbes

Mylan Laboratories won FDA approval of its generic version of GlaxoSmithKline's anti-nausea drug Zofran, prescribed for cancer patients in chemotherapy. Mylan said it plans to begin shipping its product immediately.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC